One week to go: Discover next-generation antibody production
Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies.
Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for next-generation antibody production.
This webinar ‘Next-gen antibody discovery: Leveraging DNA immunisation and single B-cell cloning for high-affinity & specificity rabbit mAbs’ is aimed at researchers, scientists, and pharmaceutical professionals aiming to enhance their antibody discovery processes.
Whether you are developing next-generation therapeutics like TCR/CAR-T or ADCs, or for use as diagnostic reagents, Fujifilm Wako’s service offers the efficiency and precision required for success.
You will learn:
- How Fujifilm Wako’s DNA immunisation technique eliminates the need for purified antigen preparation. By directly injecting plasmids into rabbits, robust immune responses are induced, producing antibodies that recognize native protein forms, including complex targets like transmembrane proteins.
- About Fujifilm’s patented single B-cell cloning method, which allows for the efficient isolation and cloning of B-cells, resulting in monoclonal antibodies with exceptional affinity and specificity.
- The superior performance of rabbit antibodies, which offer high affinity, diverse epitope recognition, and strong reactivity against rare or weak antigens. These qualities make them ideal for both therapeutic applications and diagnostic reagents.
The event will feature Albert Zhang, Field Marketing & CRO Specialist at Fujifilm Wako.
